Veradigm (NASDAQ:MDRX) Earns Hold Rating from Analysts at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX) in a research report issued on Wednesday. The brokerage set a “hold” rating on the software maker’s stock.

A number of other brokerages have also recently commented on MDRX. TD Cowen reduced their target price on shares of Veradigm from $26.00 to $15.00 and set a “buy” rating for the company in a report on Tuesday, May 28th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $10.00 target price (down from $15.00) on shares of Veradigm in a report on Tuesday, March 19th. Five equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $12.00.

Veradigm Stock Down 6.7 %

Shares of NASDAQ:MDRX opened at $9.00 on Wednesday. The company has a 50-day simple moving average of $8.53 and a 200-day simple moving average of $8.65. Veradigm has a one year low of $5.01 and a one year high of $14.09.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Charles Schwab Investment Management Inc. grew its position in Veradigm by 8.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,087,605 shares of the software maker’s stock worth $21,899,000 after buying an additional 171,199 shares during the period. Allianz Asset Management GmbH lifted its stake in shares of Veradigm by 41.2% during the fourth quarter. Allianz Asset Management GmbH now owns 343,433 shares of the software maker’s stock valued at $3,603,000 after buying an additional 100,275 shares during the period. Creative Planning lifted its stake in shares of Veradigm by 2,848.4% during the third quarter. Creative Planning now owns 474,376 shares of the software maker’s stock valued at $6,233,000 after buying an additional 458,287 shares during the period. Kent Lake Capital LLC lifted its stake in shares of Veradigm by 62.2% during the fourth quarter. Kent Lake Capital LLC now owns 1,500,000 shares of the software maker’s stock valued at $15,735,000 after buying an additional 575,000 shares during the period. Finally, Pacer Advisors Inc. lifted its stake in shares of Veradigm by 108.1% during the fourth quarter. Pacer Advisors Inc. now owns 2,516,574 shares of the software maker’s stock valued at $26,399,000 after buying an additional 1,307,024 shares during the period.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.